Highlights • LC–MS facilitates routine TDM and pharmacometabolomics toward precision dosing. • LC–MS-based bioassay methods of anti-TB drugs and metabolites was summarized. • Perspectives on numerous advancements in TB management were highlighted. • Comprehensive approach was proposed to enhance clinical outcomes and eradicate TB.
All Keywords
【저자키워드】 Tuberculosis, precision medicine, LC-MS, Therapeutic Drug Monitoring, MIPD, Pharmacometabolomics,
【저자키워드】 Tuberculosis, precision medicine, LC-MS, Therapeutic Drug Monitoring, MIPD, Pharmacometabolomics,